Electromed, Inc. (ELMD): Price and Financial Metrics
ELMD Price/Volume Stats
Current price | $17.28 | 52-week high | $17.81 |
Prev. close | $17.52 | 52-week low | $8.80 |
Day low | $16.88 | Volume | 34,900 |
Day high | $17.62 | Avg. volume | 29,202 |
50-day MA | $12.73 | Dividend yield | N/A |
200-day MA | $11.14 | Market Cap | 148.69M |
ELMD Stock Price Chart Interactive Chart >
ELMD POWR Grades
- Sentiment is the dimension where ELMD ranks best; there it ranks ahead of 92.26% of US stocks.
- ELMD's strongest trending metric is Growth; it's been moving down over the last 26 weeks.
- ELMD ranks lowest in Momentum; there it ranks in the 4th percentile.
ELMD Stock Summary
- The price/operating cash flow metric for ELECTROMED INC is higher than 88.3% of stocks in our set with a positive cash flow.
- For ELMD, its debt to operating expenses ratio is greater than that reported by just 0.22% of US equities we're observing.
- The volatility of ELECTROMED INC's share price is greater than that of merely 9.98% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to ELECTROMED INC are HSII, TRT, GO, GNE, and TLF.
- ELMD's SEC filings can be seen here. And to visit ELECTROMED INC's official web site, go to www.smartvest.com.
ELMD Valuation Summary
- ELMD's price/earnings ratio is 28.9; this is 0.86% lower than that of the median Healthcare stock.
- Over the past 163 months, ELMD's price/earnings ratio has gone down 6.7.
Below are key valuation metrics over time for ELMD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ELMD | 2023-12-29 | 1.9 | 2.4 | 28.9 | 20.3 |
ELMD | 2023-12-28 | 1.7 | 2.3 | 26.9 | 18.8 |
ELMD | 2023-12-27 | 1.8 | 2.3 | 27.3 | 19.1 |
ELMD | 2023-12-26 | 1.8 | 2.3 | 27.3 | 19.1 |
ELMD | 2023-12-22 | 1.8 | 2.4 | 28.2 | 19.8 |
ELMD | 2023-12-21 | 1.8 | 2.4 | 27.8 | 19.5 |
ELMD Growth Metrics
- Its year over year net cashflow from operations growth rate is now at -77.69%.
- Its 2 year cash and equivalents growth rate is now at -0.9%.
- Its 4 year revenue growth rate is now at 40.84%.
The table below shows ELMD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 42.316 | -1.804 | 1.947 |
2022-06-30 | 41.659 | -0.686 | 2.305 |
2022-03-31 | 39.85878 | 0.805168 | 2.32154 |
2021-12-31 | 38.50476 | 1.480121 | 1.900311 |
2021-09-30 | 37.75283 | 1.67905 | 2.265738 |
2021-06-30 | 35.756 | 3.077 | 2.362 |
ELMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ELMD has a Quality Grade of A, ranking ahead of 95.51% of graded US stocks.
- ELMD's asset turnover comes in at 0.99 -- ranking 21st of 183 Medical Equipment stocks.
- DYNT, SYK, and IRMD are the stocks whose asset turnover ratios are most correlated with ELMD.
The table below shows ELMD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.990 | 0.764 | 0.161 |
2021-03-31 | 0.943 | 0.783 | 0.196 |
2020-12-31 | 0.971 | 0.781 | 0.234 |
2020-09-30 | 0.974 | 0.777 | 0.239 |
2020-06-30 | 1.015 | 0.776 | 0.279 |
2020-03-31 | 1.102 | 0.768 | 0.301 |
Electromed, Inc. (ELMD) Company Bio
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Latest ELMD News From Around the Web
Below are the latest news stories about ELECTROMED INC that investors may wish to consider to help them evaluate ELMD as an investment opportunity.
Electromed, Inc. Announces Fiscal 2024 First Quarter Financial ResultsNEW PRAGUE, Minn., November 07, 2023--Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results |
Electromed, Inc. Announces Hospital Market Release SmartVest Clearway, Fifth Generation HFCWO Airway Clearance GeneratorNEW PRAGUE, Minn., November 01, 2023--Electromed, Inc. Announces Hospital Market Release SmartVest Clearway, Fifth Generation HFCWO Airway Clearance Generator |
Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNEW PRAGUE, Minn., November 01, 2023--Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum |
Electromed, Inc. Schedules its First Quarter Fiscal 2024 Financial Results Conference Call for November 7, 2023 at 5:00 p.m. ETNEW PRAGUE, Minn., October 24, 2023--Electromed, Inc. Schedules its First Quarter Fiscal 2024 Financial Results Conference Call for November 7, 2023 at 5:00 p.m. ET |
Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial ResultsNEW PRAGUE, Minn., August 22, 2023--Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results |
ELMD Price Returns
1-mo | 25.76% |
3-mo | 60.74% |
6-mo | 66.96% |
1-year | 71.09% |
3-year | 61.34% |
5-year | 226.04% |
YTD | 58.39% |
2023 | 4.00% |
2022 | -19.31% |
2021 | 32.52% |
2020 | 13.41% |
2019 | 69.94% |
Continue Researching ELMD
Want to see what other sources are saying about Electromed Inc's financials and stock price? Try the links below:Electromed Inc (ELMD) Stock Price | Nasdaq
Electromed Inc (ELMD) Stock Quote, History and News - Yahoo Finance
Electromed Inc (ELMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...